Skip to content

Clinical trials

Completed Phase 2 COVID-19 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Status: Completed Clear all

405 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20192
2020233
202199
202235
202324
20246
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed405

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)8
Washington University School of Medicine6
BioNTech SE5
Hipra Scientific, S.L.U5
NYU Langone Health5
Pfizer5
Stanford University5
Assistance Publique - Hôpitaux de Paris4
AstraZeneca4
Health Institutes of Turkey4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19405
Coronavirus Infections78
Severe Acute Respiratory Syndrome28
Pneumonia23
Respiratory Distress Syndrome18
Post-Acute COVID-19 Syndrome13
Respiratory Insufficiency10
Virus Diseases10
Anosmia7
Cytokine Release Syndrome6

Trials

Showing 1 to 25 of 405. Each trial links to its page on Pharma Observatory.

305 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.